Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity

Virus-specific T-cell responses can limit immunodeficiency virus type 1 (HIV-1) transmission and prevent disease progression and so could serve as the basis for an affordable, safe, and effective vaccine in humans. To assess their potential for a vaccine, we used Mycobacterium bovis bacillus Calmett...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ami, Yasushi, Izumi, Yasuyuki, Matsuo, Kazuhiro, Someya, Kenji, Kanekiyo, Masaru, Horibata, Shigeo, Yoshino, Naoto, Sakai, Koji, Shinohara, Katsuaki, Matsumoto, Sohkichi, Yamada, Takeshi, Yamazaki, Shudo, Yamamoto, Naoki, Honda, Mitsuo
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2005
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1235843/
https://ncbi.nlm.nih.gov/pubmed/16188989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.20.12871-12879.2005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires